Introduction
The family Flaviviridae contains about 70 virus members, most of which are transmitted to vertebrates by either ticks or mosquitoes and cause diseases of varying clinical manifestation and severity in humans and animals. The viruses are enveloped particles about 50 nm in diameter containing a single-stranded positive-sense RNA molecule of approximately 11 kb. The virion RNA, encoding three structural proteins, designated capsid (C), membrane (M) and envelope (E), and seven nonstructural proteins, designated NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5, is translated into a polyprotein from which structural and non-structural proteins are processed by cellular and viral proteases (Chambers et al., 1990) . The complete
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Fax j44 1865 281696. e-mail eag!ceh.ac.uk nucleotide sequences of ten tick-borne flavivirus strains are available : two Far-East Asian strains, Sofjin (Pletnev et al., 1990) and 205 (Safronov et al., 1991) ; three Central European strains, Neudorfl (Mandl et al., 1988 (Mandl et al., , 1989 (Mandl et al., , 1991 , Hypr and 263 (Wallner et al., 1996) ; three Powassan strains, isolated in Canada, USA and Russia (Mandl et al., 1993) ; British louping ill ; and a Siberian isolate, Vasilchenko (Vs) (Gritsun & Gould, 1998 ; Gritsun et al., 1997) .
The Vs strain within the tick-borne encephalitis (TBE) virus complex was isolated from a patient with a latent form of TBE. In experiments on Syrian hamsters and monkeys, Vs virus demonstrated a tendency to produce chronic disease and even latent infections that could be reactivated in the animals following immunosuppression 2 years after the initial infection (Frolova et al., 1982 a, b) . Genome sequence alignment of the Vs virus with other isolates of TBE virus demonstrated multiple nucleotide and amino acid substitutions, and phylo-T. S. Gritsun, A. Desai and E. A. Gould T. S. Gritsun, A. Desai and E. A. Gould genetic analysis identified this virus as a separate Siberian isolate of the TBE complex viruses (Gritsun et al., , 1997 Zanotto et al., 1995) .
An infectious clone of Vs virus, pGGVs, was constructed using a long, high-fidelity PCR (Gritsun & Gould, 1998 ; Gritsun et al., 1997) . Characterization of pGGVs revealed two features distinct from the Vs parental virus. Firstly, it was found that the recovered pGGVs virus had a slightly smaller plaque phenotype compared with the Vs parental virus. Secondly, parental Vs and pGGVs viruses had five nucleotide differences, four of which resulted in amino acid substitutions. Two mutations were identified as possibly being responsible for the reduced plaque phenotype of pGGVs. One of them, H %*' R (at amino acid position 496 within the polyprotein and corresponding to nucleotide substitution A "'"* G), had occurred in a highly conserved domain within the E protein.
The other nucleotide substitution, T "!))% C (nucleotide position 10884 of the genome), was located in a highly conserved domain of the 3h untranslated region (3hUTR), a proposed recognition signal for viral RNA polymerases (Gritsun et al., 1997 ; Proutski et al., 1997 ; Rauscher et al., 1997) .
Three other amino acid differences between pGGVs and Vs viruses mapped to less conserved regions of the virus genome, one in the C protein (I %& F, corresponding to nucleotide substitution A #'& T) and two others in the NS5 protein (T #'))
A and M $$)& I with corresponding nucleotide substitutions A )"*% G and G "!#)( T). In this study, the biological significance of these mutations was evaluated by site-directed mutagenesis of the infectious clone and comparative examination of engineered mutants by different biological methods. It was demonstrated that the substitution H %*' R in the E protein was solely responsible for the reduction of plaque size in cell culture. Virus mutants with R %*' also showed reduced virus yield in growth cycles, reduced cytotoxic effect in cell culture and reduced neuroinvasiveness in mice. The biological effect of the substitution C "!))% T was not as obvious as that of the substitution R %*' H, but was reproducible by cytopathic effect (CPE), cytotoxicity and neuroinvasiveness testing. The effect of mutations mapping within the C (I %& F) and NS5 (T #')) A and M $$)& I) proteins was detectable only in neuroinvasiveness tests. The pGGVs virus recovered from the infectious clone was the most attenuated of the mutant viruses when tested in animals, thus demonstrating the cumulative effect of the five mutations.
Methods
Virus and RNA extraction. TVs virus was maintained as a 10 % suspension of suckling mouse brain. Viral RNA was precipitated from 100 µl of Vs virus-infected mouse brain suspension by incubation with 1 ml Catrimox (Iowa Biotechnology), as described previously , and reconstituted in 50 µl H # O. Reverse transcription of viral RNA. First-strand cDNA was synthesized essentially as described previously .
A sample of 11 µl RNA and 5 µl of the appropriate primer (50 pM) were mixed and heated for 2 min at 95 mC. The mixture was then chilled and 3 µl dNTPs (10 mM), 3 µl DTT (0n1 mM), 1 µl RNasin (40 U), 6 µl 5ibuffer and 1 µl Superscript II reverse transcriptase (Gibco BRL) were added. The mixture was incubated at 42 mC for 1 h.
Derivation of PCR products, cloning and sequencing. PCR amplification was carried out in a volume of 50 µl using thermostable DNA polymerase purchased from Sigma. Reaction conditions were as follows : 30 cycles of 1 min at 95 mC, 1 min at 50 mC and 1 min at 72 mC.
To sequence the substitutions I %& NS5) and T "!))% C (3hUTR), five regions of the Vs viral genome, corresponding to nucleotides 1-344, 2296-2313, 8064-8983, 10000-10518 and 10415-10928 , respectively, were re-amplified by RT-PCR using Vs viral RNA and the appropriate primers. PCR products for each gene were amplified in five different tubes, pooled and purified using the QIAGEN DNA purification kit. PCR-derived DNA containing the E protein gene and the 3hUTR were then cloned using the pGEM-T vector system (Promega) to create pGEMT-E and pGEMT3hUTR, respectively (Fig. 1) . Three clones of each pGEMT-E and pGEMT-3hUTR were selected and sequenced. For the substitutions I %& F, T #'))
A and M $$)& I, PCR products were sequenced directly without cloning.
Sequencing reactions were performed as recommended using a Taq DyeDeoxy Terminator Sequencing kit (Perkin Elmer), as recommended by the manufacturer. Products were analysed using an automated Applied Biosystems 373 XL DNA sequencer.
Construction of plasmids and mutagenesis of the infectious clone. The construction of the infectious clone, pGGVs, and the basic strategy for the introduction of mutations were described previously (Gritsun & Gould, 1998) . The plasmid pGGVs was used to construct the cassette of intermediate plasmids (Fig. 1 ) to produce mutant viruses (Fig. 2) .
Construction of basic plasmids for genetic manipulations. Plasmid pGGVs ''! -"*)#del ( Fig. 1 ) was created from pGGVs by replacing the DNA fragment (part of the E gene) between the AgeI and Sse8387I restriction sites (nt 660-1982) with a short DNA linker (5h CCGGTC-CTAGACCTGC\GGTCTAG 3h ; annealing nucleotides are in bold). Plasmid pGGVs was also digested with NotI\AgeI and ligated with the linker 5h GGCCGCGACTGA\CCGGTCAGTCGC 3h to construct the intermediate plasmid pGGVs
''! -"!*#( (data not presented). The DNA fragment between nucleotides 1982 and 10927 (unique restriction sites Sse8387I and PspAI) in plasmid pGGVs ''! -"!*#( was subsequently substituted with the linker 5h GGACTTCAgcggccgcC\ CCGGGgcggccgcTGAAGTCCTGCA 3h, thereby introducing the additional NotI site (lower case) to facilitate (see below) the construction of the infectious clone (Gritsun & Gould, 1998) .
Introduction of single substitutions into the E gene and the 3hUTR of the infectious clone. To restore the wild-type Vs virus E protein containing H %*'
, the DNA fragment of pGGVs ''! -"*)# between the restriction sites BsrGI and Sse8387I (nt 1389-1982 of the genome) was substituted with the corresponding fragment from pGEMT-E ( Fig. 1 ) to create pGGVs
. To restore the wild-type Vs virus 3hUTR containing T "!))% , the DNA fragment within pGGVs ''! -"*)#del between the restriction sites BssHII and PspAI (nt 10501-10927 of the genome) was substituted with the corresponding fragment from pGEMT-3hUTR ( Fig. 1) to create pGGVs ''! -"*)#del T "!))% . The resulting plasmids were sequenced completely to verify the introduction of mutations.
Construction and recovery of mutant viruses. To re-create the full-length infectious clone, the plasmids pGGVs
(1-5 µg) were digested with NotI and TBE virus : infectious clone, E protein and 3hUTR TBE virus : infectious clone, E protein and 3hUTR were inserted between the unique restriction sites AgeI and Sse8387I to construct plasmid pGGVs , and between NotI and AgeI and Sse8387I and PspAI to construct plasmid pGGVs 660-1982del , both from pGGVs. An additional NotI restriction site was introduced into pGGVs 660-1982del with a linker. pGEMT-E and pGEMT3hUTR were made by cloning cDNA (produced by RT-PCR) from the original Vs virus into the pGEMT vector. Asterisks indicate two sites on the infectious clone, pGGVs, one within the E protein (nucleotide G 1619 with corresponding amino acid R 496 in the polyprotein) and the other within the 3hUTR (nucleotide C 10884 ), which were substituted for A 1619 and T 10884 , respectively, to reproduce the wild-type genotypes of Vs virus genome. The DNA fragments excised from pGEMT-E and pGEMT-3hUTR (dotted vertical arrows) to replace corresponding fragments in plasmids pGGVs and pGGVs 660-1982del , respectively, to introduce mutations are shown.
dephosphorylated by incubation with shrimp alkaline phosphatase (USB) for 30 min at 37 mC (Gritsun & Gould, 1998) . Plasmids pGGVs ''! -"*)# and pGGVs
, and pGGVs ''! -"*)#del and pGGVs ''! -"*)#del T "!))% were then digested with AgeI\Sse8387I and the short excised DNA linker fragments were removed using MicroSpin S-400 HR Columns (Pharmacia). Both pGGVs ''! -"*)# and pGGVs
were ligated in vitro with pGGVs ''! -"*)#del to generate full-length Vs virus cDNA. Similarly, plasmids pGGVs ''! -"*)# and pGGVs ''! -"*)# H %*' were ligated with pGGVs ''! -"*)#del T "!))% . Each mutant plasmid was sequenced completely. Plasmids were then digested with SmaI (to linearize the plasmid) and SP6 polymerase was used for transcription, as described previously (Gritsun & Gould, 1998) . SP6-transcribed RNA was inoculated intracerebrally into suckling mice to recover the mutant viruses . The presence of mutations in each mutant virus was validated by sequencing the RT-PCR products amplified from the appropriate genomic regions of virus mutants.
Plaque assays. Plaque morphology and initial titres of the virus mutants were evaluated, essentially as described previously (Gritsun & Gould, 1998) . Briefly, PS cells on 6-well plates were inoculated with tenfold dilutions of a 10 % suspension of virus-infected mouse brain. After 1 h of virus adsorption, virus inoculum was removed and cell monolayers were overlaid with 1 % low-melt-agarose (Flowgen). After T. S. Gritsun, A. Desai and E. A. Gould T. S. Gritsun, A. Desai and E. A. Gould incubation for 3-5 days at 37 mC, agarose was removed and cell monolayers were stained with naphthalene black.
Plaque assay for the estimation of virus titres in growth cycle experiments (see below) was performed on 96-well tissue culture plates. The supernatant medium from each time-point for different mutants was diluted tenfold in 100 µl Eagle's MEM (EMEM). A 100 µl sample of PS cell suspension in EMEM containing 4 % foetal calf serum (FCS) was then added to each well. After incubation for 4 h at 37 mC, an overlay containing 2 % carboxymethylcellulose with 2 % FCS was added to each well (30 µl) and the plates were incubated at 37 mC for 4 days. Plaques were visualized by staining monolayers with naphthalene black.
Virus growth cycles. Monolayers of PS cells in 24-well plates were infected with mutant viruses at an estimated m.o.i. of 10 p.f.u. per cell. Each experiment was performed in quadruplicate. The inoculum (0n1 ml) was removed after 1 h of incubation and monolayers were washed thoroughly with serum-free medium. Fresh medium (1 ml) containing 2 % FCS was then added to each well. The supernatant medium from appropriate wells was collected at different time-points (from 0 to 53 h post-infection) and frozen at k70 mC. Virus titres were estimated by plaque assay using PS cells in 96-well plates.
Estimation of CPE. PS cells in 24-well plates were infected with mutant viruses at an estimated m.o.i. of 10 p.f.u. per cell. After 48-72 h, cell destruction was observed by light microscopy. Additionally, cells were stained with naphthalene black and the intensity of cell destruction was estimated visually.
CPE caused by each mutant virus was also compared by estimating the amount of lactate dehydrogenase (LDH) retained in infected PS cell monolayers using the CytoTox 96 Non-Radioactive Cytotoxicity assay (Promega), with some modifications. PS cells in 24-well plates were infected with mutant viruses (five wells for each mutant) at an estimated m.o.i. of 10 p.f.u. per cell. The virus inoculum was removed after 1 h adsorption and substituted with 200 µl EMEM containing 2 % FCS. After incubation at 37 mC for 70-80 h, cell monolayers were washed three times with PBS and frozen at k70 mC. Lysis buffer (100 µl) was added to each well and plates were incubated at 37 mC for 45 min. Cell lysate (25 µl) from each well was transferred to 96-well assay plates and 25 µl of reconstituted substrate mixture was added. After incubation of the plates at room temperature in the dark for 30 min, 25 µl of stop solution was added and absorbance was measured at 492 nm.
Neuroinvasiveness test.
In preliminary tests, viruses were titrated by the estimation of p.f.u.\ml and intracerebral inoculation of newborn mice to obtain comparative ratios. Subsequently, in four separate experiments, 3-4-week-old mice (five in each group) were injected intraperitoneally with 2000 p.f.u. of mutant virus. Mice were observed daily for up to 4 weeks. Results were evaluated by mortality rate and average survival time (AST) of infected animals.
Results

Sequencing the E protein gene and the 3hUTR of Vs virus
The Vs virus genome has been sequenced twice previously, once from 11 overlapping bacterial clones (Gritsun et al., 1997) BGHA TBE virus : infectious clone, E protein and 3hUTR TBE virus : infectious clone, E protein and 3hUTR Table 1 . Differences between mutant viruses constructed using the infectious clone, pGGVs
The position of the mutated amino acids for the E, C and NS5 proteins and nucleotide substitution for the 3hUTR are shown in subscript. The size of each plaque (under agarose) was estimated in mm. Vs parental E %*'
Plasmids
and then as an infectious clone produced by a long, highfidelity RT-PCR (Gritsun & Gould, 1998) . Analysis of the two genome sequences revealed five nucleotide substitutions ; four mutations were located in the polyprotein and resulted in amino acid codon changes and one mutation was located in a conserved region of the 3hUTR. To test whether or not these mutations were present in the Vs parental virus population or acquired during the construction of the infectious clone, we repeatedly sequenced the five regions of Vs virus that included these mutations. Viral RNA was extracted from a 10 % suspension of virusinfected mouse brain and the five regions of the Vs virus genome were amplified by RT-PCR. To eliminate possible errors produced by reverse transcriptase and Taq polymerase, we analysed the pooled PCR products for each region of the Vs virus genome (see Methods). Nucleotide sequences of the three clones of the Vs E protein gene and three clones of the 3hUTR were determined and the amino acid sequences for the E protein were deduced. PCR products for the C and NS5 genes were sequenced directly without cloning procedures. Results show that the four amino acid substitutions between Vs (accession no. L40361) and pGGVs virus, i.e. H %*' R in the E protein (numbers show polyprotein position), I %& F in the C protein, T #')) A and M $$)& I in the NS5 protein, and one nucleotide substitution, T "!))% C, within the 3hUTR were present only in the infectious clone.
Biological properties of the engineered viruses
Plasmids pGGVs ''! -"*)# and pGGVs ''! -"*)# H %*' were ligated to plasmids pGGVs ''! -"*)#del and pGGVs ''! -"*)#del T "!))% (Fig. 1 ) in order to construct the fulllength DNA for four viruses, namely Vs-c (constructed), pGGVs-c (constructed), E(H)3hUTR(C) and E(R)3hUTR(T) (Fig.   BGHB 2). Viruses E(H)3hUTR(C) and E(R)3hUTR(T) each contained only one wild-type substitution, H %*' in the E protein or T "!))% in the 3hUTR, respectively. Virus Vs-c contained both wildtype substitutions, H %*' and T "!))% . In this respect, Vs-c was similar, but not identical, to the Vs parental virus. As shown in Fig. 2 , Vs and Vs-c viruses differed in the C (I %& F) and the NS5 (T #'))
A and M $$)& I) proteins. Viruses pGGVs and pGGVs-c have identical genotypes, but they were assembled from different plasmids (see Methods, Table 1 ). In the text of this manuscript, we shall only refer to pGGVs, although pGGVs-c was included, with identical results in all experiments. These six viruses (Fig. 2) were compared in different biological assays (see Figs 3, 4 and Table 1 ).
Plaque assay
It was demonstrated previously that virus recovered from the infectious clone, pGGVs, formed plaques that were slightly smaller than those formed by the Vs parental virus (Gritsun & Gould, 1998) . Virus E(H)3hUTR(C), containing only one wildtype substitution H %*' in the E protein, formed larger plaques than pGGVs virus containing R %*' (Table 1) . Virus E(R)3hUTR(T), containing R %*' in the E protein but wild-type T "!))% within the 3hUTR, formed plaques that were the same size as those produced by virus recovered from the infectious clone, pGGVs. Virus Vs-c, containing both wild-type substitutions, H %*' in the E protein and T "!))% in the 3hUTR, formed the same size plaques as the Vs parental virus and virus E(H)3hUTR (C), which contains only the H %*' substitution in the E protein (Table 1) .
Growth curve assay
To assess the effect of these mutations on virus replication, the growth kinetics of mutant viruses were compared with Vs virus (Fig. 3) . The results show that viruses could be grouped into two categories, those producing high virus yield ( 10( n & p.f.u.\ml) with a short lag phase of 12 h and those producing relatively low virus yield ( 10( n # p.f.u.\ml) with a long lag phase of 16 h. The viruses with a short lag phase, Vs, Vs-c and E(H)3hUTR (C), share the wild-type mutation H %*' in the E protein, whereas viruses with R %*' in the E protein produced growth curves with a long lag phase.
Cytopathic effect
The cytopathogenicity of each virus was estimated using several different methods. Firstly, we used conventional visualization of cells under the light microscope and comparative intensity of cell monolayers stained by naphthalene black after infection for 72-80 h. The results are presented in Fig. 4 and Table 1. Viruses with H %*' in the E protein [Vs, Vsc and E(H)3hUTR(C)] produced more intensive CPE than viruses with R %*' in the E protein [pGGVs and E(R)3hUTR(T)]. However, in this assay, small but reproducible differences were visualized between E(R)3hUTR(T), with only one wild-type substitution, T "!))% , in the 3hUTR, and two reference viruses pGGVs (or pGGVs-c) and E(H)3hUTR(C). CPE produced by virus E(R)3hUTR(T) was considered to be intermediate between viruses pGGVs and E(H)3hUTR(C) (Fig. 4 and Table 1 ).
The CPE caused by each mutant virus was also compared by estimating the level of retained LDH in infected PS cell monolayers using a CytoTox 96 Non-Radioactive Cytotoxicity assay. The amount of retained LDH in the infected cells was measured using an appropriate substrate and absorbance was measured at 492 nm 72 h after infection. These experiments were repeated several times. The results of BGHC TBE virus : infectious clone, E protein and 3hUTR TBE virus : infectious clone, E protein and 3hUTR this test (Fig. 5) showed that cell monolayers infected with viruses containing H %*' in the E gene retained reduced levels of LDH (i.e. more cell destruction) in comparison with noninfected cells and cells infected by viruses with R %*' in the E protein. The level of LDH in cell monolayers infected with E(R)3hUTR(T) was higher than that produced by pGGVs but lower than that produced by E(H)3hUTR(C), confirming the intermediate CPE produced by E(R)3hUTR(T).
Neuroinvasiveness test
The results presented in Table 1 show that Vs virus (parent) was more virulent than all of the viruses engineered from the infectious clone, revealing the shortest AST and the highest mortality rate. Virus pGGVs, recovered from the infectious clone, demonstrated the most attenuated properties, the longest AST and the lowest mortality rate. Surprisingly, virus Vs-c, constructed from the infectious clone and containing both wild-type mutations, H %*' in the E protein and T "!))% in the 3hUTR, demonstrated reduced neuroinvasiveness in comparison with the Vs parental virus. Virus E(H)3hUTR(C), with H %*' in the E protein, had slightly less neuroinvasiveness then Vs-c, which contains both H %*' and T "!))% wild-type mutations. Both E(H)3hUTR(C) and Vs-c had higher mortality rates and reduced AST compared with pGGVs virus. Virus containing only one wild-type mutation, T "!))% in the 3hUTR, had intermediate virulence compared with viruses recovered from the infectious clones and virus containing the wild-type substitution H %*' in the E protein (Table 1) .
endosomal membranes during virion entry into cells. Several point mutations in this conformational region affect the virulence of different flaviviruses, including mutations influencing the threshold pH for fusion leading to conformational changes (Holzmann et al., 1997 ; Rey et al., 1995) . The substitution H %*' R probably became possible as H and R are similar in size and both are positively charged, making this substitution look conserved, although it obviously affects the virulence characteristics of the virus.
Plaque assay and growth curve experiments did not demonstrate any biological effect of the T "!))% C "!))% substitution in the highly conserved region of the 3hUTR. In both of these tests, mutant virus E(R)3hUTR(T), with only one wild-type substitution T "!))% in the 3hUTR, was grouped with viruses containing C "!))% in the 3hUTR. Nevertheless the small biological effect of this mutation was noticeable in the other tests, namely CPE, cytotoxicity and neuroinvasiveness tests (Table 1 ). In the CPE (Fig. 4 ) and cytotoxicity assays (Fig. 5) , virus E(R)3hUTR(T), with only one wild-type substitution T "!))% in the 3hUTR, lysed PS cells with slightly less efficiency than its counterpart mutant virus E(H)3hUTR(C), with only one wild-type substitution H %*' in the E protein, but more efficiently than pGGVs virus, with C "!))% in the 3hUTR. The same intermediate biological effect of virus E(R)3hUTR(T) was revealed in the neuroinvasiveness test (Table 1) . Despite the fact that these effects were quite small, they were reproducible. The effect of the T "!))% C substitution in the 3hUTR was similar to that produced by a long deletion in the 3hUTR of TBE virus (Mandl et al., 1998) . In both cases, clear plaques became turbid : plaque turbidity reflects incomplete cell lysis and is probably due to a delay in the rate of virus replication, resulting from poor recognition of the disturbed stem-loop structures at the 3hUTR by the virus RNA polymerase complex. The substitution of wild-type T "!))% for mutant C "!))% in the 3hUTR probably has a similar effect on the rate of virus replication in cell culture.
The other three mutations mapped to less conserved regions of the virus genome, one in the C protein (I %& F) and the other two in the NS5 protein (T #')) A and M $$)& I). These mutations did not appear to have any effect on the rate of virus replication. Indeed, parental Vs virus and mutant Vsc, both of which contained wild-type mutations H %*' and T "!))% , produced the same biological effects in plaque assay, growth curve experiments, CPE test and cytotoxicity assay. Nevertheless, the differences between these two viruses were reproducible in neuroinvasiveness tests, where Vs-c virus showed a lower mortality rate and a longer AST. Therefore, these mutations in the C (I %& F) and NS5 (T #')) A and M $$)& I) proteins, either individually or together, were also contributing to the delayed replication rate of the virus.
The main problem in this type of research is the recognition of ' small ' biological effects produced by point mutations. There are many publications demonstrating the ' clear ' effect of point mutations that map within different regions of flavivirus genomes Hall et al., 1999 ; Holzmann et al., 1997 ; Kawano et al., 1993 ; Lee et al., 2000 ; Lindenbach & Rice, 1999 ; Muylaert et al., 1997 ; Pletnev et al., 1993 ; Pryor et al., 1998 ; Rey et al., 1995 ; Stocks & Lobigs, 1998 ; Valle & Falgout, 1998 ; Xie et al., 1998) . Each of these mutations significantly changes plaque morphology, virus growth cycle, neurovirulence and neuroinvasiveness.
We have demonstrated that it may be possible to attenuate virus by introducing a number of point mutations, each of which causes a small effect on virus virulence. The advantage of using a strategy that utilizes the cumulative effect of these mutations is that reverse mutation would not result in increased virulence. Live attenuated virus vaccine, such as yellow fever 17D, was derived empirically and is known to contain point mutations that, individually, do not necessarily induce distinctive changes in virulence. In fact, it is believed that all available live attenuated virus vaccines are based on these principles, although it has never been formally demonstrated.
This study complements the ongoing research into the molecular basis of flavivirus attenuation and could eventually lead to the development of a safe and effective live attenuated vaccine against the TBE complex viruses.
